机构:
Hoshi Univ, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Shinagawa Ku, Tokyo 1428501, JapanHoshi Univ, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Shinagawa Ku, Tokyo 1428501, Japan
Hirabayashi, Takahiro
[1
]
论文数: 引用数:
h-index:
机构:
Nakamachi, Tomoya
[2
]
Shioda, Seiji
论文数: 0引用数: 0
h-index: 0
机构:
Hoshi Univ, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Shinagawa Ku, Tokyo 1428501, JapanHoshi Univ, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Shinagawa Ku, Tokyo 1428501, Japan
Shioda, Seiji
[1
]
机构:
[1] Hoshi Univ, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Shinagawa Ku, Tokyo 1428501, Japan
[2] Univ Toyama, Grad Sch Sci & Engn, Lab Regulatory Biol, 3190 Gofuku, Toyama, Toyama 9308555, Japan
Pituitary adenylate-cyclase-activating polypeptide (PACAP) is a 27- or 38-amino acid neuropeptide, which belongs to the vasoactive intestinal polypeptide (VIP)/glucagon/secretin family. PACAP shows particularly high homology (similar to 68%) to VIP. Because of the high homology of the amino acid sequences of PACAP and VIP, these peptides share three class B-G-protein coupled receptors: the PAC1-Receptor (PAC1-R), the VPAC1-Receptor (VPAC1-R) and VPAC2-Receptor (VPAC2-R). These receptors have high homology to each other, and their high homology is utilized for these discoveries. This review provides mainly an overview of the history of the discovery of PACAP and its three receptors.
机构:
Tulane Univ, Hebert Ctr, US Japan Biomed Res Labs, Belle Chasse, LA 70037 USATulane Univ, Hebert Ctr, US Japan Biomed Res Labs, Belle Chasse, LA 70037 USA
机构:
Tulane Univ, Hebert Ctr, US Japan Biomed Res Labs, Belle Chasse, LA 70037 USATulane Univ, Hebert Ctr, US Japan Biomed Res Labs, Belle Chasse, LA 70037 USA